Future Science Group
10 files

Supplementary Tables – Clinical effectiveness outcomes and healthcare resource utilization of patients diagnosed with small-cell lung cancer

posted on 2022-06-17, 07:29 authored by Taylor & FrancisTaylor & Francis, Junji Lin, Santosh Gautam, Nan Hu, Gboyega Adeboyeje, Sumesh Kachroo


Supplemental Table 1. Summary of Treatment Distribution for Patients with eSCLC by Regimen-based Line for 1L, 2L, and 3L


Supplemental Table 2. Treatment Regimen Distribution for Patients with eSCLC by Regimen-Based Line of Treatment for 1L, 2L, and 3L


Supplemental Table 3. Healthcare Resource Utilization by Performance Status for 1L Therapy


Supplemental Table 4. Mixed Model for General Physical Symptoms


Supplemental Table 5. Mixed Model for Treatment Side Effects


Supplemental Table 6. Mixed Model for Acute Distress


Supplemental Table 7. Mixed Model for Despair


Supplemental Table 8. Mixed Model for Impaired Ambulation


Supplemental Table 9. Mixed Model for Impaired Performance


Supplemental Table 10. Demographic Characteristics, Clinical Characteristics, and Comorbidities of Patients with eSCLC by Systemic Treatment